XML 19 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 3,226 $ 2,801
Accounts receivables, net of allowance for credit losses of $95 million and $91 million as of December 31, 2023 and December 31, 2022, respectively 3,408 3,696
Inventories 4,021 3,833
Prepaid expenses 1,255 1,162
Other current assets 504 549
Assets held for sale 70 10
Total current assets 12,485 12,051
Deferred income taxes 1,812 1,458
Other non-current assets 470 441
Property, plant and equipment, net 5,750 5,739
Operating lease right-of-use assets 397 419
Identifiable intangible assets, net 5,387 6,270
Goodwill [1] 17,177 17,633
Total assets 43,479 44,011
Current liabilities:    
Short-term debt 1,672 2,109
Sales reserves and allowances 3,535 3,750
Accounts payables 2,602 1,887
Employee-related obligations 611 566
Accrued expenses 2,771 2,151
Other current liabilities 1,056 1,005
Total current liabilities 12,247 11,469
Long-term liabilities:    
Deferred income taxes 606 548
Other taxes and long-term liabilities 4,019 3,945
Senior notes and loans 18,161 19,103
Operating lease liabilities 320 349
Total long-term liabilities 23,106 23,944
Commitments and contingencies, see note 12  
Total liabilities 35,353 35,413
Teva shareholders' equity:    
Ordinary shares of NIS 0.10 par value per share; December 31, 2023 and December 31, 2022: authorized 2,495 million shares; issued 1,227 million shares and 1,217 million shares, respectively 57 57
Additional paid-in capital 27,807 27,688
Accumulated deficit (13,534) (12,975)
Accumulated other comprehensive loss (2,697) (2,838)
Treasury shares as of December 31, 2023 and December 31, 2022: 106 million ordinary shares (4,128) (4,128)
Stockholders' equity attributable to Teva shareholders 7,506 7,804
Non-controlling interests 620 794
Total equity 8,126 8,598
Total liabilities and equity $ 43,479 $ 44,011
[1] Cumulative goodwill impairment as of December 31, 2023, December 31, 2022 and December 31, 2021 was approximately $28.3 billion, $27.6 billion and $25.6 billion respectively.